BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optimized Programming in Spinal Cord Stimulation (SCS) System

Phase 4

Completed

Conditions: Neuropathic Pain
Pain

Interventions: Device: Precision Spinal Cord Stimulation (SCS)

First Posted Date: 2009-03-30

Last Posted Date: 2013-11-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 20

Registration Number: NCT00871819

Locations: 🇺🇸
University of California, San Diego Medical Center, San Diego, California, United States

Initial Chronic Human Validation Study: Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) System

Not Applicable

Completed

Conditions: Ventricular Tachyarrhythmias

Interventions: Device: Subcutaneous Implantable Defibrillator (S-ICD) System

First Posted Date: 2009-03-02

Last Posted Date: 2021-07-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 6

Registration Number: NCT00853645

Locations: 🇳🇿
Christchurch Hospital, Christchurch, New Zealand
🇳🇿
Auckland City Hospital, Auckland, New Zealand

ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Device: WATCHMAN

First Posted Date: 2009-02-26

Last Posted Date: 2015-01-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 150

Registration Number: NCT00851578

Locations: 🇩🇪
Sankt Katharinen Hospital / Cardiovasculares Centrum, Frankfurt, Germany
🇨🇿
NA Homolce Hospital, Prague, Czech Republic
🇩🇪
Herzzentrum Leipzig, Leipzig, Germany

and more 1 locations

Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -

Phase 4

Completed

Conditions: Atrial Fibrillation

Interventions: Device: Guidant Pulsar Max II or Insignia Plus DR
Device: Atrial pacing preference turned on or off

First Posted Date: 2009-02-20

Last Posted Date: 2021-05-12

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 270

Registration Number: NCT00848445

Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Device: Irinotecan Bead

First Posted Date: 2009-02-16

Last Posted Date: 2021-07-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 40

Registration Number: NCT00844233

Locations: 🇦🇹
Medical University Vienna, AKH, Vienna, Austria
🇬🇧
North Manchester General Hospital, Manchester, United Kingdom
🇫🇷
Centre Hépato-Biliaire, Hôpital Paul Brousse, Villejuif, France

and more 2 locations

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)

Phase 3

Completed

Conditions: Atherosclerosis
Coronary Artery Disease

Interventions: Device: PROMUS Element™

First Posted Date: 2009-01-16

Last Posted Date: 2012-08-30

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT00824434

Locations: 🇦🇺
Fremantle Hospital, Fremantle, Western Australia, Australia
🇸🇬
National Heart Centre Singapore, Singapore, Singapore
🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia

and more 14 locations

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: PROMUS Coronary Stent System
Device: PROMUS Element Coronary Stent System
Drug: Aspirin
Drug: Thienopyridine

First Posted Date: 2009-01-15

Last Posted Date: 2019-03-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1530

Registration Number: NCT00823212

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Washington Adventist Hospital, Takoma Park, Maryland, United States
🇺🇸
Ohio Health Research and Innovation Institute, Columbus, Ohio, United States

and more 128 locations

Evaluation of Left Ventricular AutoThreshold

Completed

Conditions: Heart Failure

Interventions: Device: No intervention is used. Collection of signals only.

First Posted Date: 2008-12-22

Last Posted Date: 2022-06-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 80

Registration Number: NCT00812201

Locations: 🇺🇸
Virginia Commonwealth University Health System, Richmond, Virginia, United States
🇺🇸
Monongalia General Hospital, Morgantown, West Virginia, United States

Safety of Bronchial Thermoplasty Performed With the Alair® System During Two Treatment Sessions to Treat Severe Asthma

Not Applicable

Withdrawn

Conditions: Asthma

Interventions: Device: The Alair System

First Posted Date: 2008-12-05

Last Posted Date: 2021-02-01

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT00803088

CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study

Not Applicable

Completed

Conditions: Coronary Artery Disease
Coronary Artery Chronic Total Occlusion

Interventions: Device: BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire)

First Posted Date: 2008-12-03

Last Posted Date: 2021-01-26

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 42

Registration Number: NCT00801710

Locations: 🇩🇪
CardioVascular Center Frankfurt, St. Katharinen Hospital, Frankfurt, Germany
🇩🇪
Universitäres Herz- und Gefässzentrum Hamburg, Hamburg, Germany
🇩🇪
Main Taunus Hospital, Bad Soden, Germany

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy